Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ovarian Cancer
Researchers describe findings in ovarian cancer studies
October 20th, 2005
Ovarian cancer research advances have been reported from the E-mail: lvl@med and United States. Study 1: Progression-free survival may be extended with paclitaxel infusion treatment. "To determine the impact of weekly paclitaxel consolidation on progression-free survival (PFS) of women undergoing treatment for ovarian cancer," researchers at the University of North Carolina at Chapel Hill identified "all women with advanced epithelial ovarian or primary peritoneal carcinoma, treated with paclitaxel consolidation therapy from August 1997 to March 2002." "Patients received weekly paclitaxel infused at a median dose of 80...
Source: Women's Health Weekly (2005-10-20)
|
